Boehringer Ingelheim Investigational Site

Berkeley, California

0 studies enrolling now · 2 studies all time

What they study most

Alzheimer Disease, HIV Infections

Studies at this site

• Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients — Completed
• An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type — Completed